Prognostic impact of microscopic residual disease after neoadjuvant chemotherapy in patients undergoing interval debulking surgery for advanced ovarian cancer

Even in the absence of macroscopic disease after NACT, the persistence of microscopic residuals predicts a poorer prognosis among AEOC patients undergoing IDS, with a trend towards worse PFS for patients with more than three affected areas. Removing all fibrotic residuals eventually hiding microscopic disease during IDS represents the key to improving the prognosis of these patients.

Authors

Institutions

Publication Details

Journal
Archives of Gynecology and Obstetrics
Published
2024-10-13
DOI
https://doi.org/10.1007/s00404-024-07775-w
Citations
11
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
5.91
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic impact of microscopic residual disease after neoadjuvant chemotherapy in patients undergoing interval debulking surgery for advanced ovarian cancer

Andrea Giannini, Giorgio Bogani, Giuseppe Caruso, Ludovico Muzii et al.
11 citations
Archives of Gynecology and Obstetrics
Ovarian cancer diagnosis and treatment
5.91
article

Prognostic impact of microscopic residual disease after neoadjuvant chemotherapy in patients undergoing interval debulking surgery for advanced ovarian cancer

Andrea Giannini, Giorgio Bogani, Giuseppe Caruso, Ludovico Muzii, Tullio Golia D’Augè, Angelina Pernazza, Pierluigi Benedetti Panici, Federica Tomao, Violante Di Donato, Innocenza Palaia, Giorgia Perniola, Carlo Della Rocca
article en
11 citations

Abstract

Even in the absence of macroscopic disease after NACT, the persistence of microscopic residuals predicts a poorer prognosis among AEOC patients undergoing IDS, with a trend towards worse PFS for patients with more than three affected areas. Removing all fibrotic residuals eventually hiding microscopic disease during IDS represents the key to improving the prognosis of these patients.

Archives of Gynecology and ObstetricsVol. 311(2)
Policlinico Umberto I (IT), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), Sapienza University of Rome (IT)
No poverty
Openalex Percentile: Top 4%
Ovarian cancer diagnosis and treatment
5.91
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.